Evidence map›Paper›PMID 41686242›Full record

ArticleAnnals of hematology2026

Machine learning and AI-Assisted red blood cell morphology analysis for effective thalassemia screening.

Ying Gui, Weiwei Chen, Yuangang Su, Caizhen Qin, Fuyong Zhang, Jinmin Zhao, Qian Liu

Abstract read
In one paragraph

Article in Annals of hematology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ying GuiCollaborative Innovation Centre of Regenerative Medicine and Medical BioResource Development and Application Co-constructed by the Province and Ministry, The First Affiliated Hospital of Guangxi Medical University, Guangxi Medical University, Nanning, 530021, Guangxi, China.
Weiwei ChenCollaborative Innovation Centre of Regenerative Medicine and Medical BioResource Development and Application Co-constructed by the Province and Ministry, The First Affiliated Hospital of Guangxi Medical University, Guangxi Medical University, Nanning, 530021, Guangxi, China.
Yuangang SuSchool of Life Sciences, Guangxi Medical University, Nanning, 530021, Guangxi, China.
Caizhen QinClinical Laboratory Center, The First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, Guangxi, China.
Fuyong ZhangClinical Laboratory Center, The First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, Guangxi, China.
Jinmin ZhaoCollaborative Innovation Centre of Regenerative Medicine and Medical BioResource Development and Application Co-constructed by the Province and Ministry, The First Affiliated Hospital of Guangxi Medical University, Guangxi Medical University, Nanning, 530021, Guangxi, China.
Qian LiuCollaborative Innovation Centre of Regenerative Medicine and Medical BioResource Development and Application Co-constructed by the Province and Ministry, The First Affiliated Hospital of Guangxi Medical University, Guangxi Medical University, Nanning, 530021, Guangxi, China. liuqian@gxmu.edu.cn.

Funding

Guangxi Natural Science Foundation 2023GXNSFDA026058Open Project of NHC Key Laboratory of Thalassemia Medicine GJWJWDP202210Self-financing Scientific Research Subject of Guangxi Health Department Z-A20220420
6 · The paper itself

Abstract

Background: Thalassemia is an inherited autosomal recessive hematologic disorder characterized by chronic hemolytic anemia due to impaired synthesis of globin chains. A three-level prevention system has effectively reduced the birth rate of affected children and enabled early intervention in Guangxi, China. However, conventional blood tests lack accuracy, and hemoglobin electrophoresis has low predictive value for α-thalassemia with low HbA₂. While genetic testing remains the gold standard, its high-cost limits large-scale use. Thus, a fast, low-cost, and reliable screening method is urgently needed for effective thalassemia control. Methods:An AI-driven detection system for intelligent recognition and quantitative analysis of erythrocyte morphology was developed using a large-scale dataset. This system was applied to both thalassemia and control samples to identify erythrocytes. The eXtreme Gradient Boosting (XGB) and logistic regression (LR) models were developed to distinguish thalassemia cases from controls, classify thalassemia subtypes, and differentiate thalassemia from iron deficiency anemia (IDA) based on the morphological features of red blood cell (RBC) identified by the system. Results: The XGB and LR models achieved AUROC values of 0.92 and 0.98, respectively, for distinguishing thalassemia cases from controls. Subclass analysis showed that the XGB model reached an AUROC of 0.99 for α-thalassemia and 0.98 for β-thalassemia, while the LR model achieved an AUROC of 0.95 for α-thalassemia and 0.99 for β-thalassemia. The LR model outperformed the XGB model (AUROC 0.88 vs. 0.75) in differentiating IDA from thalassemia. Conclusions: Both the XGB and LR models demonstrate high accuracy in predicting thalassemia and distinguishing its subtypes, based on using RBC morphological features extracted by an AI-driven detection system.

Indexed as

Artificial IntelligenceErythrocytesMachine LearningThalassemiaalpha-ThalassemiaBoosting Machine Learning AlgorithmsClassification AlgorithmsFemaleHumansMass ScreeningAI-AssistedMachine learningMorphologyRed blood cellThalassemia

Identifiers

PMID41686242
PMCPMC12904909

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.